XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.3
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 1,685 $ 17,835
Current marketable securities 1,136 3,480
Patent cross license receivable 0 4,000
Receivables, net of allowance of $325 1,868 3,279
Inventories, net 14,269 10,625
Income tax receivable 27 36
Prepaid expenses and other assets 4,054 4,062
Total current assets 23,039 43,317
Long-term marketable securities 222 916
Long-term inventories, net 2,237 3,143
Property and equipment, net 518 530
Operating lease - right of use assets, net 718 990
Intangibles, net 1,567 1,689
Other assets 78 109
Total assets 28,379 50,694
Current liabilities:    
Accounts payable 1,248 1,945
Accrued liabilities 2,057 2,290
Deferred product revenue 22 30
Total current liabilities 3,327 4,265
Operating lease liability, net of current 472 665
Other long-term liabilities 1,079 1,079
Total liabilities 4,878 6,009
Shareholders' equity:    
Common stock, par value $0.001, 50,000,000 shares authorized, 23,969,148 and 23,969,148 shares issued and outstanding, respectively 24 24
Additional paid-in capital 31,640 46,047
Accumulated other comprehensive loss (307) (310)
Accumulated deficit (7,856) (1,076)
Total shareholders' equity 23,501 44,685
Total liabilities and shareholders' equity $ 28,379 $ 50,694